Comment on "A Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Adjunctive Brexpiprazole 2 mg Daily in Japanese Patients with Major Depressive Disorder"'

被引：0
|
作者：
Wang, Chenxi [1 ]
Tian, Huichuan [1 ]
Shang, Jin [2 ]
机构：
[1] Macau Univ Sci & Technol, Fac Chinese Med, Taipa 999078, Macao, Peoples R China
[2] Hubei Univ Tradit Chinese Med, Sch Pharm, Wuhan 430065, Peoples R China
来源：
CNS DRUGS | 2025年 / 39卷 / 02期
关键词：
D O I：
10.1007/s40263-024-01152-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：209 / 210
页数：2
相关论文
共 50 条
  • [21] Long-term Safety and Efficacy of Etanercept in Patients With Psoriasis: An Open-label Study
    Leonardi, Craig
    Strober, Bruce
    Gottlieb, Alice B.
    Elewski, Boni E.
    Ortonne, Jean-Paul
    van de Kerkhof, Peter
    Chiou, Chiun-Fang
    Dunn, Meleana
    Jahreis, Angelika
    JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (08) : 928 - 937
  • [22] Long-term open-label study to evaluate the safety and efficacy of pramipexole (PPX) in Japanese patients with primary Restless Legs syndrome (RLS)
    Shimiza, T.
    Inoue, Y.
    Kuroda, K.
    Hirata, K.
    Uchimura, N.
    Kagimura, T.
    MOVEMENT DISORDERS, 2009, 24 : S446 - S447
  • [23] Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study
    Nakao Iwata
    Jun Ishigooka
    Ichiro Naoi
    Masahiro Matsumoto
    Yuichi Kanamori
    Hiroshi Nakamura
    Teruhiko Higuchi
    CNS Drugs, 2020, 34 : 103 - 116
  • [24] Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study
    Iwata, Nakao
    Ishigooka, Jun
    Naoi, Ichiro
    Matsumoto, Masahiro
    Kanamori, Yuichi
    Nakamura, Hiroshi
    Higuchi, Teruhiko
    CNS DRUGS, 2020, 34 (01) : 103 - 116
  • [25] The Long-Term Efficacy and Safety of Flexibly-Dosed Adjunctive Intranasal Oxytocin in Patients with Schizophrenia; An Open-Label Study
    Feifel, David
    MacDonald, Kai
    Cobb, Patrice
    McKinney, Rebecca
    Hadley, Allison
    BIOLOGICAL PSYCHIATRY, 2013, 73 (09) : 320S - 320S
  • [26] Efficacy and safety of OM-8980 in patients with rheumatoid arthritis: An open-label, long-term, multicenter study
    Bandilla, K
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1999, 60 (12): : 638 - 649
  • [27] A phase 3, long-term, open-label extension study evaluating the safety and tolerability of 15 and 20 mg vortioxetine in subjects with major depressive disorder
    Jacobsen, P. L.
    Harper, L.
    Serenko, M.
    Chan, S.
    Mahableshwarkar, A. R.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 97 - 98
  • [28] A MULTICENTER, OPEN-LABEL, LONG-TERM EXTENSION STUDY OF SUMMACTA AND BREVACTA TO EVALUATE SAFETY AND EFFICACY OF TOCILIZUMAB SC IN PATIENTS WITH MODERATE TO SEVERE RA
    Kivitz, A.
    Olech, E.
    Borofsky, M.
    Devenport, J.
    Pei, J.
    Wallace, T.
    Michalska, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 720 - 720
  • [29] The multimodal antidepressant Lu AA21004: open-label long-term safety and tolerability study in major depressive disorder
    Florea, I.
    Dragheim, M.
    Loft, H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S255 - S256
  • [30] Long-term tolerability, safety and efficacy of adjunctive perampanel in the open-label, dose-ascending Study 231 and extension Study 233 in Japanese patients with epilepsy
    Usui, Naotaka
    Akamatsu, Naoki
    Nakasato, Nobukazu
    Ohnishi, Akihiro
    Kaneko, Sunao
    Hiramatsu, Hidetaka
    Saeki, Kazunori
    Miyagishi, Hideaki
    Inoue, Yushi
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2018, 62 : 26 - 32
12345